Current management and treatment of cerebral vasospasm complicating SAH

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 2, 2013, Pages 233-241

  Kühn, Anna Luisa ^a   Balami, Joyce Saleh ^b   Grunwald, Iris Quasar ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Aneurysmal subarachnoid haemorrhage; Cerebral vasospasm; Diagnosis; Endovascular therapy; Medical therapy; Transcranial doppler; Triple H therapy

Indexed keywords

ALTEPLASE; CLAZOSENTAN; ERYTHROPOIETIN; INSULIN; MAGNESIUM SULFATE; MILRINONE; NICARDIPINE; NIMODIPINE; PAPAVERINE; PLACEBO; SIMVASTATIN; VERAPAMIL;

ABSENCE OF SIDE EFFECTS; ANEMIA; BRAIN VASOSPASM; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL (TOPIC); DIAGNOSTIC ACCURACY; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG EFFICACY; DRUG SAFETY; HEMODILUTION; HUMAN; HYPERTENSION; HYPERVOLEMIA; HYPOTENSION; INTRACRANIAL PRESSURE; KIDNEY FAILURE; LUNG DISEASE; LUNG EDEMA; META ANALYSIS (TOPIC); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SUBARACHNOID HEMORRHAGE; TRANSCRANIAL DOPPLER;

HUMANS; MAGNETIC RESONANCE IMAGING; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; VASOSPASM, INTRACRANIAL;

EID: 84876736233     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311312020010     Document Type: Review

References (98)

1. de Rooij, N.K.; Linn, F.H.; van der Plas, J.A.; Algra, A.; Rinkel, G.J. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J. Neurol. Neurosurg. Psychiatry, 2007, 78(12), 1365-1372.
2. Macdonald, R.L.; Pluta, R.M.; Zhang, J.H. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat. Clin. Pract. Neurol., 2007, 3(5), 256-263.
3. Janardhan, V.; Biondi, A.; Riina, H.A.; Sanelli, P.C.; Stieg, P.E.; Gobin, Y.P. Vasospasm in aneurysmal subarachnoid hemorrhage: diagnosis, prevention, and management. Neuroimaging Clin. N. Am., 2006, 16(3), 483-496, viii-ix.
4. Keyrouz, S.G.; Diringer, M.N. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit. Care, 2007, 11(4), 220.
5. Sarrafzadeh, A.S.; Haux, D.; Ludemann, L.; Amthauer, H.; Plotkin, M.; Kuchler, I.; Unterberg, A.W. Cerebral ischaemia in aneurysmal subarachnoid hemorrhage: a correlative microdialysis-PET study. Stroke, 2004, 35(3), 638-643.
6. Manno, E.M.; Gress, D.R.; Schwamm, L.H.; Diringer, M.N.; Ogilvy, C.S. Effects of induced hypertension on transcranial Doppler ultrasound velocities in patients after subarachnoid hemorrhage. Stroke, 1998, 29(2), 422-428.
7. Soehle, M.; Czosnyka, M.; Pickard, J.D.; Kirkpatrick, P.J. Continuous assessment of cerebral autoregulation in subarachnoid hemorrhage. Anesth. Analg., 2004, 98(4), 1133-1139, table of contents.
8. Lovelock, C.E.; Rinkel, G.J.; Rothwell, P.M. Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology, 2010, 74(19), 1494-1501.
9. Kassell, N.F.; Torner, J.C.; Jane, J.A.; Haley, E.C., Jr.; Adams, H.P. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J. Neurosurg., 1990, 73(1), 37-47.
10. Murayama, Y.; Malisch, T.; Guglielmi, G.; Mawad, M.E.; Vinuela, F.; Duckwiler, G.R.; Gobin, Y.P.; Klucznick, R.P.; Martin, N.A.; Frazee, J. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases. J. Neurosurg., 1997, 87(6), 830-835.
11. Yalamanchili, K.; Rosenwasser, R.H.; Thomas, J.E.; Liebman, K.; McMorrow, C.; Gannon, P. Frequency of cerebral vasospasm in patients treated with endovascular occlusion of intracranial aneurysms. AJNR Am. J. Neuroradiol., 1998, 19(3), 553-558.
12. Charpentier, C.; Audibert, G.; Guillemin, F.; Civit, T.; Ducrocq, X.; Bracard, S.; Hepner, H.; Picard, L.; Laxenaire, M.C. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke, 1999, 30(7), 1402-1408.
13. Rabinstein, A.A.; Pichelmann, M.A.; Friedman, J.A.; Piepgras, D.G.; Nichols, D.A.; McIver, J.I.; Toussaint, L.G., 3rd; McClelland, R.L.; Fulgham, J.R.; Meyer, F.B.; Atkinson, J.L.; Wijdicks, E.F. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J. Neurosurg., 2003, 98(2), 319-325.
14. Dehdashti, A.R.; Mermillod, B.; Rufenacht, D.A.; Reverdin, A.; de Tribolet, N. Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovasc. Dis., 2004, 17(1), 53-60.
15. Zaidat, O.O.; Ionita, C.C.; Hussain, S.I.; Alexander, M.J.; Friedman, A.H.; Graffagnino, C. Impact of ruptured cerebral aneurysm coiling and clipping on the incidence of cerebral vasospasm and clinical outcome. J. Neuroimaging, 2009, 19(2), 144-149.
16. Allen, G.S.; Ahn, H.S.; Preziosi, T.J.; Battye, R.; Boone, S.C.; Chou, S.N.; Kelly, D.L.; Weir, B.K.; Crabbe, R.A.; Lavik, P.J.; Rosenbloom, S.B.; Dorsey, F.C.; Ingram, C.R.; Mellits, D.E.; Bertsch, L.A.; Boisvert, D.P.; Hundley, M.B.; Johnson, R.K.; Strom, J.A.; Transou, C.R. Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N. Engl. J. Med., 1983, 308(11), 619-624.
17. Pierot, L.; Aggour, M.; Moret, J. Vasospasm after aneurysmal subarachnoid hemorrhage: recent advances in endovascular management. Curr. Opin. Crit. Care, 2010, 16(2), 110-116.
18. Pickard, J.D.; Murray, G.D.; Illingworth, R.; Shaw, M.D.; Teasdale, G.M.; Foy, P.M.; Humphrey, P.R.; Lang, D.A.; Nelson, R.; Richards, P.; et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br. Med. J., 1989, 298(6674), 636-642.
19. Vatter, H.; Guresir, E.; Berkefeld, J.; Beck, J.; Raabe, A.; du Mesnil de Rochemont, R.; Seifert, V.; Weidauer, S. Perfusiondiffusion mismatch in MRI to indicate endovascular treatment of cerebral vasospasm after subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry, 2011, 82(8), 876-883.
20. Sanelli, P.C.; Ugorec, I.; Johnson, C.E.; Tan, J.; Segal, A.Z.; Fink, M.; Heier, L.A.; Tsiouris, A.J.; Comunale, J.P.; John, M.; Stieg, P.E.; Zimmerman, R.D.; Mushlin, A.I. Using quantitative CT perfusion for evaluation of delayed cerebral ischaemia following aneurysmal subarachnoid hemorrhage. AJNR Am. J. Neuroradiol., 2011, 32(11), 2047-2053.
21. Chaudhary, S.R.; Ko, N.; Dillon, W.P.; Yu, M.B.; Liu, S.; Criqui, G.I.; Higashida, R.T.; Smith, W.S.; Wintermark, M. Prospective evaluation of multidetector-row CT angiography for the diagnosis of vasospasm following subarachnoid hemorrhage: a comparison with digital subtraction angiography. Cerebrovasc. Dis., 2008, 25(1-2), 144-150.
22. Yao, G.E.; Li, Q.; Jiang, X.J.; Liu, J.; Li, J.L.; Zhang, L.L.; Li, L.L.; Zhang, J.; Xie, P. Vasospasm after subarachnoid hemorrhage: a 3D rotational angiography study. Acta Neurochir. Suppl., 2011, 110(Pt 2), 221-225.
23. Hattingen, E.; Blasel, S.; Dumesnil, R.; Vatter, H.; Zanella, F.E.; Weidauer, S. MR angiography in patients with subarachnoid hemorrhage: adequate to evaluate vasospasm-induced vascular narrowing? Neurosurg. Rev., 2010, 33(4), 431-439.
24. Seiler, R.W.; Grolimund, P.; Aaslid, R.; Huber, P.; Nornes, H. Cerebral vasospasm evaluated by transcranial ultrasound correlated with clinical grade and CT-visualized subarachnoid hemorrhage. J. Neurosurg., 1986, 64(4), 594-600.
25. Chen, F.; Wang, X.; Wu, B. Neuroimaging research on cerebrovascular spasm and its current progress. Acta Neurochir. Suppl., 2011, 110(Pt 2), 233-237.
26. Okada, Y.; Shima, T.; Nishida, M.; Yamane, K.; Hatayama, T.; Yamanaka, C.; Yoshida, A. Comparison of transcranial Doppler investigation of aneurysmal vasospasm with digital subtraction angiographic and clinical findings. Neurosurgery, 1999, 45(3), 443-449; discussion 449-450.
27. Lysakowski, C.; Walder, B.; Costanza, M.C.; Tramer, M.R. Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: A systematic review. Stroke, 2001, 32(10), 2292-2298.
28. Wintermark, M.; Ko, N.U.; Smith, W.S.; Liu, S.; Higashida, R.T.; Dillon, W.P. Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am. J. Neuroradiol., 2006, 27(1), 26-34.
29. Deshaies, E.M.; Boulos, A.S.; Popp, A.J. Peri-operative medical management of cerebral vasospasm. Neurol. Res., 2009, 31(6), 644-650.
30. Jost, S.C.; Diringer, M.N.; Zazulia, A.R.; Videen, T.O.; Aiyagari, V.; Grubb, R.L.; Powers, W.J. Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage. J. Neurosurg., 2005, 103(1), 25-30.
31. Findlay, J.M. The present role of triple-H therapy in the management of cerebral vasospasm. World Neurosurg., 2010, 74(2-3), 244-246.
32. Sen, J.; Belli, A.; Albon, H.; Morgan, L.; Petzold, A.; Kitchen, N. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol., 2003, 2(10), 614-621.
33. Etminan, N.; Vergouwen, M.D.; Ilodigwe, D.; Macdonald, R.L. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischaemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J. Cereb. Blood Flow Metab., 2011, 31(6), 1443-1451.
34. Friedman, J.A.; Pichelmann, M.A.; Piepgras, D.G.; McIver, J.I.; Toussaint, L.G., 3rd; McClelland, R.L.; Nichols, D.A.; Meyer, F.B.; Atkinson, J.L.; Wijdicks, E.F. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery, 2003, 52(5), 1025-1031; discussion 1031-1022.
35. Kim, D.H.; Haney, C.L.; Van Ginhoven, G. Reduction of pulmonary edema after SAH with a pulmonary artery catheterguided haemodynamic management protocol. Neurocrit. Care, 2005, 3(1), 11-15.
36. Lee, K.H.; Lukovits, T.; Friedman, J.A. Triple-H therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit. Care, 2006, 4(1), 68-76.
37. Dankbaar, J.W.; Slooter, A.J.; Rinkel, G.J.; Schaaf, I.C. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit. Care, 2010, 14(1), R23.
38. Castanares-Zapatero, D.; Hantson, P. Pharmacological treatment of delayed cerebral ischaemia and vasospasm in subarachnoid hemorrhage. Ann. Intensive Care, 2011, 1(1), 12.
39. Velat, G.J.; Kimball, M.M.; Mocco, J.D.; Hoh, B.L. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomised controlled trials and meta-analyses in the literature. World Neurosurg., 2011, 76(5), 446-454.
40. Rabinstein, A.A.; Lanzino, G.; Wijdicks, E.F. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol., 2010, 9(5), 504-519.
41. Philippon, J.; Grob, R.; Dagreou, F.; Guggiari, M.; Rivierez, M.; Viars, P. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir. (Wien.), 1986, 82(3-4), 110-114.
42. Mee, E.; Dorrance, D.; Lowe, D.; Neil-Dwyer, G. Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery, 1988, 22(3), 484-491.
43. Petruk, K.C.; West, M.; Mohr, G.; Weir, B.K.; Benoit, B.G.; Gentili, F.; Disney, L.B.; Khan, M.I.; Grace, M.; Holness, R.O.; et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J. Neurosurg., 1988, 68(4), 505-517.
44. Feigin, V.L.; Rinkel, G.J.; Algra, A.; Vermeulen, M.; van Gijn, J. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology, 1998, 50(4), 876-883.
45. Onal, M.B.; Civelek, E.; Kircelli, A.; Solmaz, I.; Ugurel, S.; Narin, F.; Isikay, I.; Bilginer, B.; Yakupoglu, H. Comparison of nimodipine delivery routes in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits. Acta Neurochir. Suppl., 2011, 110(Pt 2), 23-28.
46. Saunders, F.W.; Marshall, W.J. Diltiazem: dose it affect vasospasm? Surg. Neurol., 1986, 26(2), 155-158.
47. Shibuya, M.; Suzuki, Y.; Enomoto, H.; Okada, T.; Ogura, K.; Sugita, K. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir. (Wien.), 1994, 131(1-2), 19-25.
48. Badjatia, N.; Topcuoglu, M.A.; Pryor, J.C.; Rabinov, J.D.; Ogilvy, C.S.; Carter, B.S.; Rordorf, G.A. Preliminary experience with intraarterial nicardipine as a treatment for cerebral vasospasm. AJNR Am. J. Neuroradiol., 2004, 25(5), 819-826.
49. Hoh, B.L.; Ogilvy, C.S. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg. Clin. N. Am., 2005, 16(3), 501-516, vi.
50. Haley, E.C., Jr.; Kassell, N.F.; Torner, J.C. A randomised trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J. Neurosurg., 1993, 78(4), 548-553.
51. Haley, E.C., Jr.; Kassell, N.F.; Torner, J.C. A randomised controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J. Neurosurg., 1993, 78(4), 537-547.
52. Karinen, P.; Koivukangas, P.; Ohinmaa, A.; Koivukangas, J.; Ohman, J. Cost-effectiveness analysis of nimodipine treatment after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery, 1999, 45(4), 780-784; discussion 784-785.
53. Abe, K.; Iwanaga, H.; Inada, E. Effect of nicardipine and diltiazem on internal carotid artery blood flow velocity and local cerebral blood flow during cerebral aneurysm surgery for subarachnoid hemorrhage. J. Clin. Anesth., 1994, 6(2), 99-105.
54. Oskouian, R.J., Jr.; Martin, N.A.; Lee, J.H.; Glenn, T.C.; Guthrie, D.; Gonzalez, N.R.; Afari, A.; Vinuela, F. Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial doppler ultrasonographic velocities, and cerebral artery diameters. Neurosurgery, 2002, 51(1), 30-41; discussion 41-33.
55. Sawada, M.; Hashimoto, N.; Tsukahara, T.; Nishi, S.; Kaku, Y.; Yoshimura, S. Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm. Acta Neurochir. (Wien.), 1997, 139(8), 706-711.
56. Vajkoczy, P.; Horn, P.; Bauhuf, C.; Munch, E.; Hubner, U.; Ing, D.; Thome, C.; Poeckler-Schoeninger, C.; Roth, H.; Schmiedek, P. Effect of intra-arterial papaverine on regional cerebral blood flow in haemodynamically relevant cerebral vasospasm. Stroke, 2001, 32(2), 498-505.
57. Elliott, J.P.; Newell, D.W.; Lam, D.J.; Eskridge, J.M.; Douville, C.M.; Le Roux, P.D.; Lewis, D.H.; Mayberg, M.R.; Grady, M.S.; Winn, H.R. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J. Neurosurg., 1998, 88(2), 277-284.
58. Stiefel, M.F.; Spiotta, A.M.; Udoetuk, J.D.; Maloney-Wilensky, E.; Weigele, J.B.; Hurst, R.W.; LeRoux, P.D. Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen. Neurocrit. Care, 2006, 4(2), 113-118.
59. Kimball, M.M.; Velat, G.J.; Hoh, B.L. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit. Care, 2011, 15(2), 336-341.
60. Feng, L.; Fitzsimmons, B.F.; Young, W.L.; Berman, M.F.; Lin, E.; Aagaard, B.D.; Duong, H.; Pile-Spellman, J. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am. J. Neuroradiol., 2002, 23(8), 1284-1290.
61. Keuskamp, J.; Murali, R.; Chao, K.H. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J. Neurosurg., 2008, 108(3), 458-463.
62. Albanese, E.; Russo, A.; Quiroga, M.; Willis, R.N., Jr.; Mericle, R.A.; Ulm, A.J. Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article. J. Neurosurg., 2010, 113(4), 913-922.
63. Shankar, J.J.; dos Santos, M.P.; Deus-Silva, L.; Lum, C. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. Neuroradiology, 2011, 53(2), 123-128.
64. Fraticelli, A.T.; Cholley, B.P.; Losser, M.R.; Saint Maurice, J.P.; Payen, D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke, 2008, 39(3), 893-898.
65. Beck, J.; Raabe, A. Clazosentan: prevention of cerebral vasospasm and the potential to overcome infarction. Acta Neurochir. Suppl., 2011, 110(Pt 2), 147-150.
66. Kramer, A.; Fletcher, J. Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis. Stroke, 2009, 40(10), 3403-3406.
67. Macdonald, R.L.; Higashida, R.T.; Keller, E.; Mayer, S.A.; Molyneux, A.; Raabe, A.; Vajkoczy, P.; Wanke, I.; Bach, D.; Frey, A.; Marr, A.; Roux, S.; Kassell, N. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, doubleblind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol., 2011, 10(7), 618-625.
68. Macdonald, R.L.; Higashida, R.T.; Keller, E.; Mayer, S.A.; Molyneux, A.; Raabe, A.; Vajkoczy, P.; Wanke, I.; Bach, D.; Frey, A.; Nowbakht, P.; Roux, S.; Kassell, N. Randomised trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke, 2012, 43(6), 1463-1469.
69. Amin-Hanjani, S.; Ogilvy, C.S.; Barker, F.G., 2nd. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery, 2004, 54(2), 326-334; discussion 334-325.
70. McGirt, M.J.; Blessing, R.; Alexander, M.J.; Nimjee, S.M.; Woodworth, G.F.; Friedman, A.H.; Graffagnino, C.; Laskowitz, D.T.; Lynch, J.R. Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. J. Neurosurg., 2006, 105(5), 671-674.
71. Aoki, T.; Kataoka, H.; Ishibashi, R.; Nozaki, K.; Hashimoto, N. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke, 2008, 39(4), 1276-1285.
72. Bulsara, K.R.; Coates, J.R.; Agrawal, V.K.; Eifler, D.M.; Wagner-Mann, C.C.; Durham, H.E.; Fine, D.M.; Toft, K. Effect of combined simvastatin and cyclosporine compared with simvastatin alone on cerebral vasospasm after subarachnoid hemorrhage in a canine model. Neurosurg. Focus, 2006, 21(3), E11.
73. Lynch, J.R.; Wang, H.; McGirt, M.J.; Floyd, J.; Friedman, A.H.; Coon, A.L.; Blessing, R.; Alexander, M.J.; Graffagnino, C.; Warner, D.S.; Laskowitz, D.T. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomised clinical trial. Stroke, 2005, 36(9), 2024-2026.
74. Tseng, M.Y.; Czosnyka, M.; Richards, H.; Pickard, J.D.; Kirkpatrick, P.J. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischaemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomised placebo-controlled trial. Stroke, 2005, 36(8), 1627-1632.
75. Kramer, A.H.; Gurka, M.J.; Nathan, B.; Dumont, A.S.; Kassell, N.F.; Bleck, T.P. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery, 2008, 62(2), 422-427; discussion 427-430.
76. Chou, S.H.; Smith, E.E.; Badjatia, N.; Nogueira, R.G.; Sims, J.R., 2nd; Ogilvy, C.S.; Rordorf, G.A.; Ayata, C. A randomised, doubleblind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke, 2008, 39(10), 2891-2893.
77. Kern, M.; Lam, M.M.; Knuckey, N.W.; Lind, C.R. Statins may not protect against vasospasm in subarachnoid haemorrhage. J. Clin. Neurosci., 2009, 16(4), 527-530.
78. Vergouwen, M.D.; Meijers, J.C.; Geskus, R.B.; Coert, B.A.; Horn, J.; Stroes, E.S.; van der Poll, T.; Vermeulen, M.; Roos, Y.B. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomised trial. J. Cereb. Blood Flow Metab., 2009, 29(8), 1444-1453.
79. van den Bergh, W.M.; Algra, A.; van der Sprenkel, J.W.; Tulleken, C.A.; Rinkel, G.J. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery, 2003, 52(2), 276-281; discussion 281-272.
80. Saver, J.L. Target brain: neuroprotection and neurorestoration in ischaemic stroke. Rev. Neurol. Dis., 2010, 7(Suppl 1), S14-S21.
81. van den Bergh, W.M.; Algra, A.; van Kooten, F.; Dirven, C.M.; van Gijn, J.; Vermeulen, M.; Rinkel, G.J. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomised controlled trial. Stroke, 2005, 36(5), 1011-1015.
82. Wong, G.K.; Poon, W.S.; Chan, M.T.; Boet, R.; Gin, T.; Ng, S.C.; Zee, B.C. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomised, doubleblinded, placebo-controlled, multicenter phase III trial. Stroke, 2010, 41(5), 921-926.
83. Dorhout Mees, S.M.; Algra, A.; Vandertop, W.P.; van Kooten, F.; Kuijsten, H.A.; Boiten, J.; van Oostenbrugge, R.J.; Al-Shahi Salman, R.; Lavados, P.M.; Rinkel, G.J.; van den Bergh, W.M. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet, 2012, 380(9836), 44-49.
84. Celik, M.; Gokmen, N.; Erbayraktar, S.; Akhisaroglu, M.; Konakc, S.; Ulukus, C.; Genc, S.; Genc, K.; Sagiroglu, E.; Cerami, A.; Brines, M. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischaemic injury. Proc. Natl. Acad. Sci. USA, 2002, 99(4), 2258-2263.
85. Kumral, A.; Ozer, E.; Yilmaz, O.; Akhisaroglu, M.; Gokmen, N.; Duman, N.; Ulukus, C.; Genc, S.; Ozkan, H. Neuroprotective effect of erythropoietin on hypoxic-ischaemic brain injury in neonatal rats. Biol. Neonate, 2003, 83(3), 224-228.
86. Tseng, M.Y.; Hutchinson, P.J.; Richards, H.K.; Czosnyka, M.; Pickard, J.D.; Erber, W.N.; Brown, S.; Kirkpatrick, P.J. Acute systemic erythropoietin therapy to reduce delayed ischaemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomised, double-blind, placebo-controlled trial. Clinical article. J. Neurosurg., 2009, 111(1), 171-180.
87. Springborg, J.B.; Moller, C.; Gideon, P.; Jorgensen, O.S.; Juhler, M.; Olsen, N.V. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial. Acta Neurochir. (Wien.), 2007, 149(11), 1089-1101; discussion 1101.
88. Bilotta, F.; Spinelli, A.; Giovannini, F.; Doronzio, A.; Delfini, R.; Rosa, G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomised prospective pilot trial. J. Neurosurg. Anesthesiol., 2007, 19(3), 156-160.
89. Fisher, C.M.; Kistler, J.P.; Davis, J.M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery, 1980, 6(1), 1-9.
90. Findlay, J.M. A randomised trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery, 1995, 37(5), 1026-1027.
91. Musahl, C.; Henkes, H.; Vajda, Z.; Coburger, J.; Hopf, N. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage. Neurosurgery, 2011, 68(6), 1541-1547; discussion 1547.
92. Lylyk, P.; Vila, J.F.; Miranda, C.; Ferrario, A.; Romero, R.; Cohen, J.E. Partial aortic obstruction improves cerebral perfusion and clinical symptoms in patients with symptomatic vasospasm. Neurol. Res., 2005, 27(Suppl 1), S129-S135.
93. Appelboom, G.; Strozyk, D.; Hwang, B.Y.; Prowda, J.; Badjatia, N.; Helbok, R.; Meyers, P.M. Bedside use of a dual aortic balloon occlusion for the treatment of cerebral vasospasm. Neurocrit. Care, 2010, 13(3), 385-388.
94. McAuliffe, W.; Townsend, M.; Eskridge, J.M.; Newell, D.W.; Grady, M.S.; Winn, H.R. Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm. J. Neurosurg., 1995, 83(3), 430-434.
95. Carhuapoma, J.R.; Qureshi, A.I.; Tamargo, R.J.; Mathis, J.M.; Hanley, D.F. Intra-arterial papaverine-induced seizures: case report and review of the literature. Surg. Neurol., 2001, 56(3), 159-163.
96. Barr, J.D.; Mathis, J.M.; Horton, J.A. Transient severe brain stem depression during intraarterial papaverine infusion for cerebral vasospasm. AJNR Am. J. Neuroradiol., 1994, 15(4), 719-723.
97. Frontera, J.A.; Gowda, A.; Grilo, C.; Gordon, E.; Johnson, D.; Winn, H.R.; Bederson, J.B.; Patel, A. Recurrent vasospasm after endovascular treatment in subarachnoid hemorrhage. Acta Neurochir. Suppl., 2011, 110(Pt 2), 117-122.
98. Zubkov, Y.N.; Nikiforov, B.M.; Shustin, V.A. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir. (Wien.), 1984, 70(1-2), 65-79.